Ask Warren

Hyundai Pharmaceutical

004310 · KOSPI · ₩004310 · 현대약품

₩6,850▲ ₩150 (2.24%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +78.39%
Market cap
₩219B
Enterprise value
₩261B
P/E
79.1×
P/B
1.7×
Dividend yield
0.4%
ROE
2.2%
Net margin
1.4%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−57.1% from the high

₩3,500Today: ₩6,730 – ₩7,110₩15,960

Returns

  • 1W−10.0%
  • 1M−22.7%
  • 3M+29.5%
  • 6M−22.1%
  • YTD−19.6%
  • 1Y+78.4%
Volume today
489,404
0.4× the 20-day average
Traded today
₩3.4B
Listed shares
32,000,000
EPS (12 months)
₩87
Earnings yield 1.3%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

33Quiet
  • BuzzQuietBuzz 33 of 100 (50 is a normal day for this stock).
  • SentimentMixedNews: The report covers a routine next step in an approval process, with no clear positive or negative signal. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-23.5% over the last month; the price is below its 20-day average.
  • News impactSome3 news items and filings in two weeks; 0 rated high impact, 1 medium.

Signals describe activity, not recommendations. Not financial advice.

Hyundai Pharmaceutical stock overview

Hyundai Pharmaceutical (현대약품, KRX: 004310) is listed on KOSPI, in the Biotech & Pharma sector. The company manufactures and sells prescription (ETC) and over-the-counter (OTC) pharmaceuticals, along with food, cosmetics and medical devices, supplying hospitals, clinics, pharmacies and wholesalers in South Korea. Its shares closed at ₩6,850 on Oct 27, 2026, up 2.24% on the day, giving it a market value of ₩219B.

Key facts

Market cap
₩219B
Sector
Biotech & Pharma
Latest price change
+2.24%
As of
Oct 27, 2026
Main business
The company manufactures and sells prescription (ETC) and over-the-counter (OTC) pharmaceuticals, along with food, cosmetics and medical devices, supplying hospitals, clinics, pharmacies and wholesalers in South Korea.

Quick answers about Hyundai Pharmaceutical

What does Hyundai Pharmaceutical do?
The company manufactures and sells prescription (ETC) and over-the-counter (OTC) pharmaceuticals, along with food, cosmetics and medical devices, supplying hospitals, clinics, pharmacies and wholesalers in South Korea. Its key products include the dementia treatment Diemduo, the hair-loss brand Minoxyl, the fiber beverage Miero Fiber, and the skincare brand LABCLE, with production at its Cheonan and Hapcheon plants.
What is the market cap of Hyundai Pharmaceutical?
The market capitalisation of Hyundai Pharmaceutical was ₩219B at the close on Oct 27, 2026.
Who are the largest shareholders of Hyundai Pharmaceutical?
According to the latest official filings, the largest reported holders are Shinpoong Pharm (7.21%, as of Mar 4, 2026); National Pension Service (0.58%, as of Dec 31, 2025); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.14%, as of Jul 31, 2026).
When is the next earnings report from Hyundai Pharmaceutical?
Korean companies rarely announce results dates in advance. Based on when Hyundai Pharmaceutical filed the same report in past years, its next annual results is expected between Feb 13, 2027 and Feb 21, 2027.
Does the National Pension Service own Hyundai Pharmaceutical?
Yes. The National Pension Service held 0.58% of Hyundai Pharmaceutical shares as of Dec 31, 2025.

Company profile

The company manufactures and sells prescription (ETC) and over-the-counter (OTC) pharmaceuticals, along with food, cosmetics and medical devices, supplying hospitals, clinics, pharmacies and wholesalers in South Korea. Its key products include the dementia treatment Diemduo, the hair-loss brand Minoxyl, the fiber beverage Miero Fiber, and the skincare brand LABCLE, with production at its Cheonan and Hapcheon plants.

Written by AI from the company's latest annual report.

Korean name
현대약품
Sector
Biotech & Pharma
Themes
Pharmaceuticals
CEO
이상준
Founded
Jul 1965
Listed
Jun 1978
Listed shares
32,000,000
Fiscal year ends
Month 11
Website
www.hyundaipharm.co.kr

Similar companies

Recent news

News · Yonhap News Agency·

Hyundai Pharmaceutical: "Supplementary data for abortion pill approval to be submitted by next month"

Hyundai Pharmaceutical₩6,850▲2.24%
Read the original ↗

Predicted impact: Medium

Supplementary data for abortion pill approval due next month; approval outcome uncertain, company is small (about ₩214B value).

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Hyundai Pharmaceutical / 현대약품 / 004310 / KRX:004310

Source: KRX statistical information